177 related articles for article (PubMed ID: 36515128)
1. Development of Mitochondria Targeting AIE-Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents.
Kumari G; Gupta A; Sah RK; Gautam A; Saini M; Gupta A; Kushawaha AK; Singh S; Sasmal PK
Adv Healthc Mater; 2023 Apr; 12(9):e2202411. PubMed ID: 36515128
[TBL] [Abstract][Full Text] [Related]
2. Platinum(ii)-chloroquine complexes are antimalarial agents against blood and liver stages by impairing mitochondrial function.
Macedo TS; Villarreal W; Couto CC; Moreira DRM; Navarro M; Machado M; Prudêncio M; Batista AA; Soares MBP
Metallomics; 2017 Nov; 9(11):1548-1561. PubMed ID: 28960224
[TBL] [Abstract][Full Text] [Related]
3. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Barnes KI; White NJ
Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
[TBL] [Abstract][Full Text] [Related]
4. Multistage and transmission-blocking tubulin targeting potent antimalarial discovered from the open access MMV pathogen box.
Kumari G; Jain R; Kumar Sah R; Kalia I; Vashistha M; Singh P; Prasad Singh A; Samby K; Burrows J; Singh S
Biochem Pharmacol; 2022 Sep; 203():115154. PubMed ID: 35798201
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
6. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
7. Local emergence in Amazonia of
Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
Elife; 2020 May; 9():. PubMed ID: 32394893
[TBL] [Abstract][Full Text] [Related]
8. Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir.
Chaurasiya A; Kumari G; Garg S; Shoaib R; Anam Z; Joshi N; Kumari J; Singhal J; Singh N; Kaushik S; Kahlon AK; Dubey N; Maurya MK; Srivastava P; Marothia M; Joshi P; Gupta K; Saini S; Das G; Bhattacharjee S; Singh S; Ranganathan A
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0039222. PubMed ID: 36374050
[TBL] [Abstract][Full Text] [Related]
9. Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex.
Morais CMG; Brito RMM; Weselucha-Birczyńska A; Pereira VSS; Pereira-Silva JW; Menezes A; Pessoa FAC; Kucharska M; Birczyńska-Zych M; Ríos-Velásquez CM; de Andrade-Neto VF
Front Cell Infect Microbiol; 2022; 12():1047269. PubMed ID: 36530433
[TBL] [Abstract][Full Text] [Related]
10. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
11. Dinuclear and mononuclear metal(II) polypyridyl complexes against drug-sensitive and drug-resistant Plasmodium falciparum and their mode of action.
Lai JW; Maah MJ; Tan KW; Sarip R; Lim YAL; Ganguly R; Khaw LT; Ng CH
Malar J; 2022 Dec; 21(1):386. PubMed ID: 36528584
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites.
Bai Y; Zhang J; Geng J; Xu S; Deng S; Zeng W; Wang Z; Ngassa Mbenda HG; Zhang J; Li N; Wu Y; Li C; Liu H; Ruan Y; Cao Y; Yang Z; Cui L
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):320-328. PubMed ID: 29793059
[TBL] [Abstract][Full Text] [Related]
13. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
14. A small-molecule inhibitor of the DNA recombinase Rad51 from
Vydyam P; Dutta D; Sutram N; Bhattacharyya S; Bhattacharyya MK
J Biol Chem; 2019 May; 294(20):8171-8183. PubMed ID: 30936202
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum.
Agarwal D; Singh S; Gupta RD; Awasthi SK
Acta Trop; 2019 Nov; 199():105109. PubMed ID: 31351071
[TBL] [Abstract][Full Text] [Related]
16. The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures.
Bouzón-Arnáiz I; Avalos-Padilla Y; Biosca A; Caño-Prades O; Román-Álamo L; Valle J; Andreu D; Moita D; Prudêncio M; Arce EM; Muñoz-Torrero D; Fernàndez-Busquets X
BMC Biol; 2022 Oct; 20(1):197. PubMed ID: 36271358
[TBL] [Abstract][Full Text] [Related]
17. Targeting malaria parasites with novel derivatives of azithromycin.
Burns AL; Sleebs BE; Gancheva M; McLean KT; Siddiqui G; Venter H; Beeson JG; O'Handley R; Creek DJ; Ma S; Frölich S; Goodman CD; McFadden GI; Wilson DW
Front Cell Infect Microbiol; 2022; 12():1063407. PubMed ID: 36530422
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
19. Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages.
Coertzen D; Reader J; van der Watt M; Nondaba SH; Gibhard L; Wiesner L; Smith P; D'Alessandro S; Taramelli D; Wong HN; du Preez JL; Wu RWK; Birkholtz LM; Haynes RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866868
[TBL] [Abstract][Full Text] [Related]
20. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
